Additionally, IgA anti-MAA antibodies have been associated with increased coronary artery calcium, insulin resistance, and decreased high-density lipoprotein particle number, in addition to improving the 10-year prediction of coronary atherosclerosis in RA beyond that afforded by the standard cardiovascular risk calculation [31]. This evidence concerns the gene NAA10 and rheumatoid arthritis.